Skip to content
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
Archyde

Archyde

  • News
  • World
  • Economy
  • Technology
  • Health
  • Entertainment
  • Sport

tirzepatide

Science Review Links GLP-1 Drugs to Lower Dementia Risk

Science Review Links GLP-1 Drugs to Lower Dementia Risk

November 22, 2026 by Health Desk

A new review in Science finds GLP-1 drugs like semaglutide and tirzepatide are linked to lower dementia risk in people with diabetes, but two large trials showed semaglutide did not slow early Alzheimer’s disease.

Categories Health Tags Dementia risk, GLP-1 receptor agonists, semaglutide, tirzepatide, type 2 diabetes, University of Copenhagen

Recent Posts

  • Israel Investigates Torching of Palestinian Vehicles and Property in West Bank Villages
  • Science Review Links GLP-1 Drugs to Lower Dementia Risk
  • Proposed 10% Credit Card Rate Cap May Undercut SoFi Personal Loan Product
  • Bayern Leadership’s Public Criticism of Musiala Sparks Backlash from FIFPRO and AGM
  • How to Watch Saints vs. Bears: TVNZ+ VPN, Kickoff Time, and Week 11 Preview
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
© 2026 Archyde — All Rights Reserved. Contact | Privacy Policy